For teens, online bullying worsens sleep and depression

Teens who experience cyberbullying are more likely to suffer from poor sleep, which in turn raises levels of depression, found a University at Buffalo study. Although research has examined the relationship between online bullying and depression, the UB study is one of few to explore the connection between cyber victimization and sleep quality. The study surveyed more than 800 adolescents […]

Continue reading »

Oral aspirin does not up FIT test sensitivity for ID’ing CRC

(HealthDay)—Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms, according to a study published in the May 7 issue of the Journal of the American Medical Association. Hermann Brenner, M.D., M.P.H., from the German Cancer Research Center in Heidelberg, and colleagues conducted a randomized trial in […]

Continue reading »

FDA approves treatments for heart failure caused by rare disease

(HealthDay)—Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules have been approved to treat adults with cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM), the U.S. Food and Drug Administration announced today. Recommended dosage is four 20-mg capsules of Vyndaqel once daily or a single 61-mg capsule of Vyndamax once daily, according to the manufacturer. The two drugs, which are the first approved […]

Continue reading »

Making the invisible visible: New method opens unexplored realms for liquid biopsies

Advancing technology is allowing scientists increasingly to search for tiny signs of cancer and other health issues in samples of patients’ blood and urine. These “liquid biopsies” are less invasive than a traditional biopsy, and can provide information about what’s happening throughout the body instead of just at a single site. Now researchers at the University of Michigan Rogel Cancer […]

Continue reading »

Maternal comorbidity higher for women with congenital heart defects

(HealthDay)—Pregnant women with congenital heart defects (CHDs) are more likely to have comorbidities and experience adverse events during delivery, according to a study published in the May 7 issue of the Journal of the American College of Cardiology. Using multivariable logistic regression, Lauren E. Schlichting, Ph.D., of the Hassenfeld Child Health Innovation Institute at Brown University in Providence, Rhode Island, […]

Continue reading »

Benlysta approved for children with lupus

(HealthDay)—The intravenous drug Benlysta (belimumab) has been approved by the U.S. Food and Drug Administration to treat children with lupus, a chronic disease that triggers inflammation and damages tissues and organs throughout the body. Approved for adults since 2011, Benlysta is the first lupus treatment in the United States approved for children, the agency said in a news release. “While […]

Continue reading »

Global HER2 testing survey raises questions about priorities for breast cancer resources

A global survey of HER2 testing has raised questions about how resources should be spent on potentially lifesaving HER2 targeted therapies for breast cancer, especially in poorer countries. The results were presented at the ESMO Breast Cancer Congress 2019, Berlin, 2-4 May 2019. The ONCOLLEGE-001 internet-based survey of HER2 testing in 45 countries has highlighted major access and affordability issues […]

Continue reading »

Rapidly detecting cancer markers for diagnosis

Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radiation can be used to rapidly detect makers for breast-cancer cells. The scientists present a technique that makes use of the binding properties of aptamers, synthetic organic molecules acting as probes for cancer cells. Breast cancer is the most common cancer in women. Detecting it […]

Continue reading »
1 11 12 13 14 15 42